tiprankstipranks
Lipocine (LPCN)
NASDAQ:LPCN
US Market

Lipocine (LPCN) Income Statement

Compare
885 Followers

Lipocine Income Statement

Last quarter (Q3 2024), Lipocine's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Lipocine's net income was $-2.22M. See Lipocine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ -2.85M$ 500.00K$ 16.14M$ 0.00$ 164.99K
Gross Profit
$ -2.85M$ 500.00K$ 16.14M$ 0.00$ 164.99K
Operating Expenses
$ 15.08M$ 11.80M$ 16.64M$ 20.65M$ 12.83M
Depreciation and Amortization
$ 28.66K$ 9.45K$ 380.00$ 3.55K$ 15.44K
EBITDA
$ -16.32M$ -10.72M$ -430.53K$ -17.99M$ -12.65M
Operating Income
$ -17.93M$ -12.12M$ 3.15M$ -18.00M$ -12.90M
Other Income/Expenses
$ 1.58M$ 1.36M$ -3.78M$ -2.97M$ -106.85K
Pretax Income
$ -16.35M$ -10.76M$ -634.20K$ -20.96M$ -13.01M
Net Income
$ -16.35M$ -10.76M$ -634.40K$ -20.96M$ -13.01M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.14$ -2.15$ -0.19$ -6.46$ -8.54
Diluted EPS
$ -3.14$ -2.05$ -0.12$ -6.40$ -8.54
Weighted Average Shares Outstanding
5.27M 4.99M 3.30M 3.25M 1.52M
Weighted Average Shares Outstanding (Diluted)
5.27M 5.26M 5.15M 3.28M 1.52M
Currency in USD

Lipocine Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis